This finding was consistent with a previous report which revealed that GDF15 had a higher sensitivity and specificity than FGF21 when used as a biomarker for mitochondrial diseases associated with respiratory chain defects [24]. This evidence concerns the gene GDF15 and inborn mitochondrial metabolism disorder.